PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteStopping a GLP-1-based weight-management medicine commonly puts lost weight at risk of returning, but the amount and timing vary widely. In the 2024 SURMOUNT-4 withdrawal trial, people who switched from tirzepatide to placebo regained an average of 14.0% of their week-36 weight over the next 52 weeks, while people who continued treatment lost another 5.5%. Those figures describe a selected clinical-trial population—not a personal forecast. Stopping can also allow blood pressure, glucose regulation, lipids, or obesity-related complications to worsen again, so a prescriber-guided plan and follow-up matter.
First, identify which medicine and why you take it
“GLP-1 drug” is everyday shorthand for several different medicines and indications. Some medicines primarily activate the glucagon-like peptide-1 (GLP-1) receptor. Tirzepatide activates both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, so it is a dual GIP/GLP-1 agonist rather than a GLP-1-only drug. Approved uses, doses, and product labels differ by medicine and jurisdiction.
As an Amazon Associate I earn from qualifying purchases.
The reason for treatment changes the safety question. A person using a medicine for chronic weight management needs a plan for maintaining weight-related benefits. A person also using it for type 2 diabetes, or another condition, needs a plan for that condition as well. Results from an obesity trial in people without diabetes cannot be treated as a complete answer to diabetes management.
What the strongest withdrawal trial found
How SURMOUNT-4 was designed
SURMOUNT-4 was a phase 3 randomized-withdrawal trial reported in JAMA in 2024. It took place at 70 sites in Argentina, Brazil, Taiwan, and the United States. Adults with obesity, or overweight plus a weight-related complication, but without diabetes, first received open-label tirzepatide for 36 weeks. Participants also received lifestyle counseling. Of the 670 people who entered the randomized phase, one group continued tirzepatide and the other switched to placebo for 52 weeks.
#1 Best Overall
- 𝑹𝒆𝒍𝒊𝒂𝒃𝒍𝒆 𝑷𝒓𝒆𝒄𝒊𝒔𝒊𝒐𝒏: With professional expertise refined over 10 years, our brand design ensures accuracy and reliability through high-precision sensor technology
- 𝑬𝒂𝒔𝒚 𝒕𝒐 𝑼𝒔𝒆: The scale is equipped with an easy-to-read display with automatic on/off, low battery, and overload indications. Choose between 2 units of measurement (lb/kg) for your weighing convenience
- 𝑴𝒊𝒏𝒊𝒎𝒂𝒍 𝑫𝒆𝒔𝒊𝒈𝒏: Never Let a scale ruin your style. Place this scale in your bathroom, bedroom, or living room. It will complement the design of your living space
- 𝑨 𝑫𝒖𝒓𝒂𝒃𝒍𝒆 𝑪𝒉𝒐𝒊𝒄𝒆: The scale’s 6-mm tempered glass platform provides exceptional durability and comfort. Equipped with a supportive frame and anti-skid paddings to prevent slipping, you can rely on the sturdiness of our scale
- 𝑳𝒂𝒓𝒈𝒆 𝑷𝒍𝒂𝒕𝒇𝒐𝒓𝒎: Step onto the scale comfortably with its large 11.9 x 11.9-inch platform
By the end of the 36-week lead-in, the randomized participants had lost an average of 20.9% of their starting weight. The withdrawal comparison then measured change from week 36 to week 88.
The results, with the denominators kept clear
| Measure | Continued tirzepatide | Switched to placebo |
|---|---|---|
| Mean change from week 36 to week 88 | Additional 5.5% weight reduction | 14.0% mean regain of week-36 weight |
| Participants maintaining at least 80% of their lead-in weight loss at week 88 | 89.5% | 16.6% |
The 14.0% figure is a percentage of the weight participants had at week 36; it is not 14 percentage points of everyone’s original body weight and not a guaranteed amount for an individual. For example, someone weighing 100 kg at randomization into the withdrawal phase would have a trial-average regain of about 14 kg only if that person matched the group mean; individual outcomes can be lower, higher, or absent. The trial’s conclusion was that “withdrawing tirzepatide led to substantial regain of lost weight, whereas continued treatment maintained and augmented initial weight reduction.”
What this trial cannot tell you
- It did not study every GLP-1 medicine.
- It did not include people with type 2 diabetes.
- Everyone in the randomized phase had tolerated and completed a 36-week tirzepatide lead-in, so the participants were not a cross-section of everyone who starts treatment.
- It tested a planned switch to placebo, not every form of abrupt or unplanned stopping in routine care.
- Lifestyle counseling continued throughout, meaning the results do not isolate medication from all other support.
These limits are why the trial is useful evidence that regain is a substantial risk, not a formula for predicting one person’s result or deciding whether to stop.
Recommended Free Tools
Rank #2
- 𝗨𝗻𝗺𝗮𝘁𝗰𝗵𝗲𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻: With 10 years of expertise, we’re trusted by over 5 million customers in 30+ countries. we take pride in our high-precision sensors—the core tech that's responsible for the accuracy in increments down to 0.05 lb
- 𝗪𝗲𝗶𝗴𝗵𝘁 𝗩𝗲𝗿𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗗𝗼𝘂𝗯𝗹𝗲 𝗖𝗵𝗲𝗰𝗸 𝗧𝗲𝗰𝗵: Experience unmatched convenience and accuracy. Simply step on, and the scale quickly checks and ensures precise results—no need to tap or wait for the display to show zero
- 𝗠𝗲𝗮𝘀𝘂𝗿𝗲 𝗟𝗶𝗴𝗵𝘁 𝗜𝘁𝗲𝗺𝘀: Such a versatile scale. Not only can measure your body weight, but also easily weigh items as light as 100g like pets and their food with pinpoint accuracy
- 𝗘𝗮𝘀𝘆 𝘁𝗼 𝗥𝗲𝗮𝗱: Best choice for the elderly. The extra-bright LED display with large and clear numbers make it easy to read for all especially for the seniors, no need bending over or wearing presbyopic glasses
- 𝗨𝘁𝗺𝗼𝘀𝘁 𝗦𝗮𝗳𝗲 𝗮𝗻𝗱 𝗔𝗲𝘀𝘁𝗵𝗲𝘁𝗶𝗰: Expertly designed in California, our stylish scale fits seamlessly in your bedroom/bathroom/home. The sleek round corners, large anti-skid padding, and full-coverage bottom ensure durability and stability
Why weight may return after treatment is withdrawn
While treatment is active, its effects can help a person maintain the lower weight achieved during the trial. When the medicine is removed, that pharmacologic support is no longer being provided. Appetite, eating patterns, and other weight-regulation pressures may change, but the available sources do not establish a single timetable or a uniform response for everyone.
Weight recurrence does not mean that a person has failed or that all lost weight must return. Some people regain part of the loss, some regain more, and some maintain substantial loss. The SURMOUNT-4 averages show the direction and scale of risk in one carefully defined group; they do not assign an inevitable outcome to an individual.
Other health measures can drift as weight returns
The American Diabetes Association (ADA) states in its 2025 Standards of Care in Overweight and Obesity that clinicians should “Continue obesity medications after reaching treatment goals to maintain health benefits, as discontinuation often results in weight recurrence and worsening or reemergence of cardiometabolic risk factors or obesity-related diseases and complications.”
Rank #3
- ⚖️ 10-Year Accuracy with 4 G-Sensors: Equipped with 4 upgraded G-sensors for ±0.1 lb / 0.05 kg precision, this scale uses two long-lasting AAA batteries to provide stable power and consistent readings. Its optimized circuit design has been tested to deliver reliable accuracy for at least 10 years of daily use—ideal for routine morning weigh-ins and long-term tracking. 2*AAA Batteries Included
- 🔁 Quick kg / lb / st Switching for Everyday Tracking: One-button unit switching makes it easy to compare numbers with gym equipment, fitness apps, or medical checkups. Supports 180 kg / 400 lb / 28 st and fits seamlessly into real daily routines—morning weight checks, intermittent fasting logs, weekly fitness tracking, and shared bathroom use
- ⚡ Instant Step-On Results for Busy Mornings & Night Use: Delivers fast, stable measurements the moment you step on—no tapping, no setup. The bright backlit LED display stays clear during early-morning weigh-ins, low-light bathrooms, post-shower checks, and night-time measurements. Auto-calibration ensures consistency across repeated daily use
- 🛡️ Reinforced Safety Design: Constructed with 6 mm tempered glass, rounded corners, a reinforced internal frame, and an anti-slip base, this scale is designed for long-term durability and daily reliability. Ideal for wet bathroom floors after showers, kids stepping on out of curiosity, seniors checking weight daily, and frequent users during weight-loss cycles
- 🧩 Compact 26 cm Footprint—Fits Small Bathrooms & Modern Spaces: At 10.2 × 10.2 × 0.87 in, this slim digital scale fits under cabinets, next to toilets, in small apartments, dorm bathrooms, home gyms, or bedside wellness setups. The smooth tempered-glass surface wipes clean easily—great for users who weigh in daily, track fitness progress, or maintain long-term health routines
In practical terms, improvements associated with weight loss may weaken if weight returns. Depending on a person’s underlying health, that can include blood-pressure control, glucose regulation, blood-lipid levels, or complications linked to obesity. The guideline describes a risk of worsening or reemergence; it does not say that every person will experience every change or that a particular measurement will deteriorate by a predictable amount.
If the medicine is treating diabetes, stopping may also change the person’s glucose-management needs independently of the scale. The diabetes prescriber should decide how glucose will be monitored and whether another treatment is needed. An obesity-trial percentage should never be used as a substitute for a diabetes care plan.
Appetite, stomach symptoms, and other effects after stopping
People often ask whether nausea, diarrhea, constipation, vomiting, abdominal discomfort, reflux, or appetite changes disappear immediately. The reviewed sources do not quantify how quickly these effects resolve, how often they persist, or whether everyone experiences a rebound in appetite after stopping.
Rank #4
- Professional Accuracy: With 15 years experience, 20,000+ times reliablility test and advanced patented SaluOptim Tech, this weight scale ensures exceptional precision for your health and fitness
- Optimal Size & Easy-to-Read: With 11.8*11.8 inch platform, you can stand comfortably on your bath scale(Maximum capacity 450lb/205kg). Besides, sleek design, the bright, large LED digital display enables easy reading
- Safe and Durable: Designed with full-coverage base and 6mm tempered glass, the scale is sturdy and durable which is safe for the elderly and children. Also, the 4*AAA batteries included can long last for 18 months
- Special Features: Swithed to Family Mode, the weight of your baby/pet can be calculated automatically by patented Famicare Tech. Besides, light items under 22lb such as packages or pet foods can be measured precisely with the increment down to 0.05lb
- Meet High Standards: The Ovutek scale stands up to the highest standards for everyday users. We genuinely hope to leave you amazed and provide an unforgettable experience
The current US prescribing information for tirzepatide injection (Zepbound), revised August 2026, lists nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, fatigue, hair loss, and gastroesophageal reflux disease among common on-treatment adverse reactions. That label describes effects while taking the medicine; it does not provide a reliable post-discontinuation timetable. Do not assume that a symptom will stop on a specific day, and contact the prescribing clinician about symptoms that are severe, persistent, or concerning.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What can be inferred about semaglutide versus tirzepatide?
It is reasonable to expect that withdrawal evidence may differ by molecule, dose, treatment duration, population, and follow-up. Those details must be kept separate when comparing studies.
| Comparison factor | Why it matters |
|---|---|
| Molecule | Tirzepatide is a dual GIP/GLP-1 agonist; a GLP-1-only medicine such as semaglutide is not the same intervention. |
| Indication and population | Results in adults with obesity without diabetes cannot be assumed to apply to people taking a medicine for diabetes. |
| Lead-in duration | The amount of weight lost and the time spent on treatment before withdrawal influence what happens afterward. |
| Withdrawal design | A randomized switch to placebo is different from an unplanned interruption or a clinician-guided switch to another treatment. |
| Outcome definition | A percentage of week-36 body weight is not interchangeable with a percentage of the weight previously lost. |
The cited SURMOUNT-4 paper references a 2022 extension of the STEP 1 semaglutide trial on weight regain and cardiometabolic effects after withdrawal. The full extension results are not used here to give a numerical semaglutide prediction. Until the original study details are checked, the safe conclusion is that semaglutide and tirzepatide should not be assigned one shared regain percentage.
Best Value
- DURABLE ACCURACY CHOICE - Our owned professional factory has been focusing on high quality scales SINCE 2001, we make the digital scale for body weight with best-in-class technology and expertise, and proudly guarantee capacity 400lb/182kg in high 0.1lb/0.05kg division throughout the bathroom scale lifecycle. It helps you to stay fit and monitor your health.
- EASY TO USE - The weight scale is utilized up-to-date digital technology, along with many friendly features, including: auto calibration, auto step-on, auto power off, comfortable platform in 10.9'' x 10.9'', 3*AAA batteries included, 3 units switch: lb/kg/st. Easy for healthy progress or weight loss.
- EASILY VISIBLE LED - The digital scales for body weight are equipped with crystal clear LED in large number size, specially designed for clearly viewing numbers in any conditions, and kept the same brightness throughout batteries' lifecycle.
- EASILY VISIBLE LED - The digital scales for body weight are equipped with crystal clear LED in large number size, specially designed for clearly viewing numbers in any conditions, and kept the same brightness throughout batteries' lifecycle. Whether bodybuilding or just daily fitness, our scale supports your goals.
- BEYOND OUR DIGITAL SCALE - Based on over 20 years focusing on scales, our professional scales digital weight factory has been certified by ISO and Social Accountability for quality and social responsibility. All Vitafit Scale proudly developed and produced by ourselves. All Vitafit products are supported by our US customer service center in the heartland state Missouri. Vitafit: Inspired by Life, for Better Life.
How to plan a possible stop with your clinician
Do not create a taper or replacement schedule from an online article. A prescriber can weigh the original indication, current dose, response, side effects, other medicines, pregnancy plans where relevant, and access to follow-up.
- Contact the prescribing clinician before changing the dose. Explain whether you are considering a planned stop, have missed doses, or are stopping because of side effects, cost, supply, or another concern. The reason affects the safest next step.
- Separate each treatment goal. Ask what will replace the medicine’s role in weight management and, separately, how diabetes or another treated condition will be managed.
- Agree on measurements to follow. The plan may include body weight, symptoms, blood pressure, glucose data, or laboratory tests selected by the care team. The ADA recommends close monitoring when medication is stopped.
- Set a review date. A scheduled check-in makes it easier to respond to a trend before a small change becomes a larger clinical problem.
- Discuss maintenance options. The ADA recommends continuing obesity medication after treatment goals when appropriate because stopping often leads to weight recurrence and return of cardiometabolic or obesity-related problems. Whether continuation, a switch, or discontinuation is right is an individualized decision.
Using a home scale without overinterpreting it
A digital bathroom scale can be an optional way to observe a weight trend after a medication change. It is not a diagnostic device, does not treat obesity, and cannot replace follow-up. If you use one, record readings in a consistent way and share the trend—not a single day’s number—with your clinician. The purpose is early communication, not self-directed dose changes.
If weight begins to return
Contact the care team rather than waiting for a predetermined amount of regain. The clinician may review whether the medication was stopped for a reversible reason, whether another indication needs attention, and whether a maintenance or alternative strategy is appropriate. The response should account for blood pressure, glucose, lipids, symptoms, and obesity-related complications, not only the scale.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Avoid treating the SURMOUNT-4 average as a target, a deadline, or proof that all lost weight will come back. Likewise, do not assume that a short-term stable weight means cardiometabolic risk is permanently protected. Monitoring is useful precisely because the direction and speed of change differ among people.
The practical bottom line
Stopping a GLP-1-based medicine is often followed by some weight recurrence, and the risk can be substantial. In SURMOUNT-4, planned withdrawal of tirzepatide produced a 14.0% mean regain of week-36 weight over 52 weeks, while continued treatment produced another 5.5% loss; those findings apply to the trial population, not automatically to you. Other benefits can weaken as well, particularly when the medicine was helping control diabetes or obesity-related cardiometabolic risk. Discuss any change with the prescriber, make a monitoring plan, and treat the specific medicine and indication—not the generic label “GLP-1”—as the starting point for the decision.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
